The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Altitude Sickness

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Altitude Sickness


Psychiatry related information on Altitude Sickness

  • In a trial to assess the cognitive impairment attributable to benign acute mountain sickness (AMS) and to acetazolamide, six women and five men, 20-35 years old, ascended from sea-level to 3600 m in 36 h and were assessed for deterioration in performance on psychological tests [5].

High impact information on Altitude Sickness


Chemical compound and disease context of Altitude Sickness


Biological context of Altitude Sickness


Anatomical context of Altitude Sickness

  • As compared with the subjects who received placebo, those who received nifedipine had a significantly lower mean systolic pulmonary artery pressure, alveolar-arterial pressure gradient of oxygen and symptom score of acute mountain sickness at 4559 m [17].

Gene context of Altitude Sickness


Analytical, diagnostic and therapeutic context of Altitude Sickness


  1. Prevention of acute mountain sickness by dexamethasone. Johnson, T.S., Rock, P.B., Fulco, C.S., Trad, L.A., Spark, R.F., Maher, J.T. N. Engl. J. Med. (1984) [Pubmed]
  2. Acetazolamide: a treatment for chronic mountain sickness. Richalet, J.P., Rivera, M., Bouchet, P., Chirinos, E., Onnen, I., Petitjean, O., Bienvenu, A., Lasne, F., Moutereau, S., León-Velarde, F. Am. J. Respir. Crit. Care Med. (2005) [Pubmed]
  3. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Ward, A., Clissold, S.P. Drugs (1987) [Pubmed]
  4. The effect of naproxen on acute mountain sickness and vascular responses to hypoxia. Meehan, R.T., Cymerman, A., Rock, P., Fulco, C.S., Hoffman, J., Abernathy, C., Needleman, S., Maher, J.T. Am. J. Med. Sci. (1986) [Pubmed]
  5. Cognitive impairment of acute mountain sickness and acetazolamide. White, A.J. Aviation, space, and environmental medicine. (1984) [Pubmed]
  6. JAMA patient page. Altitude sickness. Stevens, L.M. JAMA (2002) [Pubmed]
  7. Acute mountain sickness and acetazolamide. Clinical efficacy and effect on ventilation. Larson, E.B., Roach, R.C., Schoene, R.B., Hornbein, T.F. JAMA (1982) [Pubmed]
  8. Carbon dioxide breathing and mountain sickness. Hackett, P.H. Lancet (1989) [Pubmed]
  9. Effect of carbon dioxide in acute mountain sickness: a rediscovery. Harvey, T.C., Raichle, M.E., Winterborn, M.H., Jensen, J., Lassen, N.A., Richardson, N.V., Bradwell, A.R. Lancet (1988) [Pubmed]
  10. Methazolamide in acute mountain sickness. Forster, P. Lancet (1982) [Pubmed]
  11. Phenytoin and acute mountain sickness on Mount Everest. Wohns, R.N., Colpitts, M., Clement, T., Karuza, A., Blackett, W.B., Foutch, R., Larson, E. Am. J. Med. (1986) [Pubmed]
  12. Nifedipine does not prevent acute mountain sickness. Hohenhaus, E., Niroomand, F., Goerre, S., Vock, P., Oelz, O., Bärtsch, P. Am. J. Respir. Crit. Care Med. (1994) [Pubmed]
  13. Migraine, polycythemia and chronic mountain sickness. Arregui, A., León-Velarde, F., Cabrera, J., Paredes, S., Vizcarra, D., Umeres, H. Cephalalgia : an international journal of headache. (1994) [Pubmed]
  14. Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Grissom, C.K., Roach, R.C., Sarnquist, F.H., Hackett, P.H. Ann. Intern. Med. (1992) [Pubmed]
  15. Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness. Tissot van Patot, M.C., Leadbetter, G., Keyes, L.E., Bendrick-Peart, J., Beckey, V.E., Christians, U., Hackett, P. J. Appl. Physiol. (2005) [Pubmed]
  16. Non-invasive measurement of circulation time using pulse oximetry during breath holding in chronic hypoxia. Zubieta-Calleja, G.R., Zubieta-Castillo, G., Paulev, P.E., Zubieta-Calleja, L. J. Physiol. Pharmacol. (2005) [Pubmed]
  17. Prevention and treatment of high altitude pulmonary edema by a calcium channel blocker. Oelz, O., Maggiorini, M., Ritter, M., Noti, C., Waber, U., Vock, P., Bärtsch, P. International journal of sports medicine. (1992) [Pubmed]
  18. Atrial natriuretic peptide in acute mountain sickness. Bärtsch, P., Shaw, S., Franciolli, M., Gnädinger, M.P., Weidmann, P. J. Appl. Physiol. (1988) [Pubmed]
  19. Usual clinical dose of acetazolamide does not alter cerebral blood flow velocity. Huang, S.Y., McCullough, R.E., McCullough, R.G., Micco, A.J., Manco-Johnson, M., Weil, J.V., Reeves, J.T. Respiration physiology. (1988) [Pubmed]
  20. The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude. Grissom, C.K., Richer, L.D., Elstad, M.R. Chest (2005) [Pubmed]
  21. Magnesium for the prevention and treatment of acute mountain sickness. Dumont, L., Lysakowski, C., Tramèr, M.R., Junod, J.D., Mardirosoff, C., Tassonyi, E., Kayser, B. Clin. Sci. (2004) [Pubmed]
  22. Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness. Bernhard, W.N., Schalick, L.M., Delaney, P.A., Bernhard, T.M., Barnas, G.M. Aviation, space, and environmental medicine. (1998) [Pubmed]
WikiGenes - Universities